These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10858975)

  • 1. Effect of valsartan on renal handling of uric acid in healthy subjects.
    González-Ortiz M; Mora-Martínez JM; Martínez-Abundis E; Balcázar-Muñoz BR
    J Nephrol; 2000; 13(2):126-8. PubMed ID: 10858975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal handling of uric acid assessed by means of pharmacological tests in obese women.
    González-Ortiz M; Martínez-Abundis E; Mora-Martínez JM; Grover-Páez F
    Diabetes Nutr Metab; 2001 Aug; 14(4):189-94. PubMed ID: 11716287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evaluation of urate renal handling in humans: pyrazinamide test vs combined pyrazinamide and probenecid administration.
    Colussi G; Rombolà G; De Ferrari ME; Rolando P; Surian M; Malberti F; Minetti L
    Nephrol Dial Transplant; 1987; 2(1):10-6. PubMed ID: 3110689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of uric acid transport in renal tubules using benzbromarone and pyrazinamide.
    Moriwaki Y; Yamamoto T; Takahashi S; Hada T; Higashino K
    Int J Clin Pharmacol Ther Toxicol; 1990 Feb; 28(2):84-8. PubMed ID: 2307550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of valsartan on the angiotensin II pressor response in healthy normotensive male subjects.
    Morgan JM; Palmisano M; Piraino A; Hirschhorn W; Spencer S; Prasad PP; Ortiz M; Lloyd P
    Clin Pharmacol Ther; 1997 Jan; 61(1):35-44. PubMed ID: 9024172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of exercise on urate excretion].
    Goto H; Ito A; Mikami T
    Nihon Seirigaku Zasshi; 1989; 51(7):208-20. PubMed ID: 2810133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal handling of hypoxanthine and xanthine in normal subjects and in four cases of idiopathic renal hypouricemia.
    Kaneko K; Fujimori S; Itoh H; Nakayama Y; Oyama H; Kanbayashi T; Miyashita H; Akaoka I
    J Rheumatol; 1988 Feb; 15(2):325-30. PubMed ID: 3361540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutral effect of valsartan on serum uric acid and renal function tests.
    Sayin T; Döven O; Akyürek O ; Dinçer I
    J Hum Hypertens; 2001 Jun; 15(6):435-6. PubMed ID: 11439321
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal handling of uric acid in normal children by means of the pyrazinamide and sulfinpyrazone tests.
    Sanchez Bayle M; Vazquez Martul M; Ecija Peiro JL; Garcia Vao C; Ramo Mancheño C
    Int J Pediatr Nephrol; 1987; 8(1):5-8. PubMed ID: 3583558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypouricemia due to an isolated defect in renal tubular urate reabsorption.
    Fujiwara Y; Takamitsu Y; Ueda N; Orita Y; Abe H
    Clin Nephrol; 1980 Jan; 13(1):44-8. PubMed ID: 6988121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of angiotensin II on pulse wave velocity in humans is mediated through angiotensin II type 1 (AT(1)) receptors.
    Rehman A; Rahman AR; Rasool AH
    J Hum Hypertens; 2002 Apr; 16(4):261-6. PubMed ID: 11967720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal handling of uric acid in normal subjects by means of the pyrazinamide and probenecid tests.
    Garcia Puig J; Mateos Antón F; Muñoz Sanz A; Gaspar G; Lesmes A; Ramos T; Ortiz Vázquez J
    Nephron; 1983; 35(3):183-6. PubMed ID: 6633758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II infusion with and without angiotensin II type 1 receptor blockade on nitric oxide metabolism and endothelin in human beings: a placebo-controlled study in healthy volunteers.
    Gossmann J; Burkhardt R; Harder S; Lenz T; Sedlmeyer A; Klinkhardt U; Haak T; Geiger H; Scheuermann EH
    Clin Pharmacol Ther; 2000 Nov; 68(5):501-9. PubMed ID: 11103753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypouricemia by defect in the tubular reabsorption.
    Barrientos A; Perez-Diaz V; Diaz-Gonzalez R; Rodicio JL
    Arch Intern Med; 1979 Jul; 139(7):787-9. PubMed ID: 454067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL; Schmieder RE; Azizi M; Aldigier JC; Januszewicz A; Zidek W; Chiang Y; Satlin A
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T; Smith TR; Glazer R; Wernsing M; Yen J; Jin J; Schneider H; Pospiech R
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypouricemia due to renal tubular defect. A study with the probenecid-pyrazinamide test.
    Smetana SS; Bar-Khayim Y
    Arch Intern Med; 1985 Jul; 145(7):1200-3. PubMed ID: 4015266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK; Leung CB; Chow KM; Cheng YL; Fung SK; Mak SK; Tang AW; Wong TY; Yung CY; Yung JC; Yu AW; Szeto CC;
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of prednisone and azathioprine (Imuran) on renal excretion of uric acid.
    Malý J; Nádvorníková H; Schück O
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):44-6. PubMed ID: 7056604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.